Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 7540.016 | 1.0776 | 1.1646 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 7540.016 | 0.9519 | 0.8984 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 7540.016 | 0.9090 | 0.8080 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.267 | uM | 7540.016 | 1.0054 | 1.0114 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 7540.016 | 0.8655 | 0.7166 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 7540.016 | 0.6819 | 0.3339 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 7540.016 | 0.8621 | 0.7095 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 7540.016 | 0.8006 | 0.5807 | 0.9455 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.000427 | uM | 7923.016 | 0.6167 | -0.0738 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 7923.016 | 0.6781 | 0.0773 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 7923.016 | 0.5831 | -0.1528 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 7923.016 | 0.6757 | 0.0715 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.267 | uM | 7923.016 | 0.6242 | -0.0557 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 7923.016 | 0.5101 | -0.3152 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 7923.016 | 0.4899 | -0.3580 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 7923.016 | 0.5385 | -0.2536 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 7923.016 | 0.5290 | -0.2746 | 0.6280 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.000427 | uM | 9878.019 | 0.9829 | 0.9769 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 9878.019 | 0.9345 | 0.9105 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 9878.019 | 0.9918 | 0.9889 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 9878.019 | 0.9954 | 0.9938 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.267 | uM | 9878.019 | 1.0015 | 1.0020 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 9878.019 | 0.9788 | 0.9713 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 9878.019 | 0.7158 | 0.5953 | 1.4790 | ||
| SUM52PE | HR+ | Luminal | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 9878.019 | 0.5889 | 0.3982 | 1.4790 |